Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL6068383

SARS-COV-2 VIRUS, INACTIVATED
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
No structure available

Basic Information

ChEMBL ID CHEMBL6068383
Name SARS-COV-2 VIRUS, INACTIVATED
Phase Approved
Structure Type NONE
Therapeutic ✓ Yes

Known Names

Covid-19 vaccine (inactivated, adjuvanted) valneva Sars-cov-2 virus, inactivated
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
2
Known Names
2
Indications
1
Mechanisms

Drug Information

Molecule Type Vaccine component
First Approval 2022
Availability Unknown
Chirality Single Enantiomer
USAN Stem vir-

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Biological vaccine - induces immune response - -

Indications

COVID-19 Vaccination

Data from ChEMBL 36 via Core Engine